Eli Lilly is on a buying spree. Here’s what it means for investors like us

Daniel Acker | Bloomberg | Getty Images

Eli Lilly (LLY) is wisely broadening out its drug pipeline through a series of acquisitions of smaller companies – the most recent of which was disclosed earlier this week and should strengthen the Club holding’s efforts to develop cancer treatments.

Source link

Leave a Comment